Category: General Biotechnology

U.N. Calls for Clone Ban

The United Nations has called on countries to ban all forms of human cloning “incompatable with human dignity.” The American religious right claims victory, but others say the declaration is the result of political maneuvering influenced by pressure from the United States.


Click here for reuse options!
Copyright 2005 Biotechblog

Will California’s Stem Cell Initiative Reap Royalties?

When the backers of California’s stem cell initiative were seeking voter support last year, they not only promised cures for dread diseases, but also licensing revenue for the state. A statement posted on the initiative proponents’ CuresforCalifornia.com Web site says that ‘California will benefit for decades from patents and royalties that result from the research.’ […]


Click here for reuse options!
Copyright 2005 Biotechblog

Will California's Stem Cell Initiative Reap Royalties?

When the backers of California’s stem cell initiative were seeking voter support last year, they not only promised cures for dread diseases, but also licensing revenue for the state. A statement posted on the initiative proponents’ CuresforCalifornia.com Web site says that ‘California will benefit for decades from patents and royalties that result from the research.’ […]


Click here for reuse options!
Copyright 2005 Biotechblog

FDA Plans New Board To Monitor Drug Safety

The Food and Drug Administration will create an independent board to more aggressively monitor the safety of drugs on the market as part of an effort to restore public confidence in the nation’s prescription drug supply, Health and Human Services Secretary Mike Leavitt announced yesterday.


Click here for reuse options!
Copyright 2005 Biotechblog

More Roadblocks Ahead For Pharma in 2005?

The pharmaceutical industry was traumatized in 2004 when Merck had to withdraw its $2.5 billion COX-2 inhibitor Vioxx from the market due to potentially lethal side effects. Pharmaceutical companies are already struggling to deal with increasing generic competition and stringent approval standards in an effective manner. Will the aftereffects of a disastrous 2004 hamper industry […]


Click here for reuse options!
Copyright 2005 Biotechblog

Genetically Modified IP Launched

Genetically Modified IP Launched A paper appearing in this week’s edition of Nature is antiseptically entitled: ‘Gene transfer to plants by diverse species of bacteria.’ But the information that lies within may herald a revolution in biology.


Click here for reuse options!
Copyright 2005 Biotechblog

From the laboratory to the investment fund

From the laboratory to the investment fund How two Chilean scientists turned a graduate thesis into a business that is helping salmon and ham producers


Click here for reuse options!
Copyright 2005 Biotechblog

Biotech: A Big Future Behind It?

Biotech: A Big Future Behind It? Despite a bumpy 2004, the rush to market hasn’t abated. The key for this crop of newcomers: Holding investors’ attention?


Click here for reuse options!
Copyright 2005 Biotechblog

The State of Stem Cell Research

The State of Stem Cell Research Californians are hoping that stem cell research will do for them what the invention of the car did for Michigan


Click here for reuse options!
Copyright 2005 Biotechblog

The Human Genome, Take Two

The Human Genome, Take Two When a sequenced human genome was announced in 2001, most people missed a crucial part of the news: the genome was a first draft, sketchy and incomplete. This fall, scientists completed a new draft. The more complete version reveals that humans have a few thousand fewer genes than was previously […]


Click here for reuse options!
Copyright 2005 Biotechblog

%d bloggers like this: